Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
Proc Natl Acad Sci U S A ; 112(47): 14682-7, 2015 Nov 24.
Article in English | MEDLINE | ID: mdl-26575624

ABSTRACT

Phosphatidylserine (PS) receptors contribute to two crucial biological processes: apoptotic clearance and entry of many enveloped viruses. In both cases, they recognize PS exposed on the plasma membrane. Here we demonstrate that phosphatidylethanolamine (PE) is also a ligand for PS receptors and that this phospholipid mediates phagocytosis and viral entry. We show that a subset of PS receptors, including T-cell immunoglobulin (Ig) mucin domain protein 1 (TIM1), efficiently bind PE. We further show that PE is present in the virions of flaviviruses and filoviruses, and that the PE-specific cyclic peptide lantibiotic agent Duramycin efficiently inhibits the entry of West Nile, dengue, and Ebola viruses. The inhibitory effect of Duramycin is specific: it inhibits TIM1-mediated, but not L-SIGN-mediated, virus infection, and it does so by blocking virus attachment to TIM1. We further demonstrate that PE is exposed on the surface of apoptotic cells, and promotes their phagocytic uptake by TIM1-expressing cells. Together, our data show that PE plays a key role in TIM1-mediated virus entry, suggest that disrupting PE association with PS receptors is a promising broad-spectrum antiviral strategy, and deepen our understanding of the process by which apoptotic cells are cleared.


Subject(s)
Dengue Virus/physiology , Ebolavirus/physiology , Membrane Glycoproteins/metabolism , Phosphatidylethanolamines/metabolism , Receptors, Virus/metabolism , Virion/metabolism , West Nile virus/physiology , Animals , Apoptosis/drug effects , Bacteriocins/metabolism , Bacteriocins/pharmacology , Dengue/virology , Dengue Virus/drug effects , Ebolavirus/drug effects , Hemorrhagic Fever, Ebola/virology , Hepatitis A Virus Cellular Receptor 1 , Humans , Jurkat Cells , Ligands , Membranes/drug effects , Mice , Peptides/metabolism , Peptides/pharmacology , Phagocytosis/drug effects , Receptors, Cell Surface/metabolism , Virus Internalization/drug effects , West Nile Fever/virology , West Nile virus/drug effects
2.
Article in English | MEDLINE | ID: mdl-38922462

ABSTRACT

Adolescence is a developmental period in which social interactions are critical for mental health. While the onset of COVID-19 significantly disrupted adolescents' social environments and mental health, it remains unclear how adolescents have adapted to later stages of the pandemic. We harnessed a machine learning architecture of Long Short-Term Memory recurrent networks (LSTM) with gradient-based feature importance, to model the association among daily social interactions and depressive symptoms during three stages of the pandemic. A year before COVID-19, 148 adolescents reported social interactions and depressive symptoms, every day for 21 days. One hundred sixteen of these youths completed a 28-day diary after schools closed due to COVID-19. Seventy-nine of these youths and additional 116 new participants completed a 28-day diary approximately a year into the pandemic. Our results show that LSTM successfully predicted depressive symptoms from at least a week of social interactions for all three waves (r2 > .70). Our study shows the utility of using an analytic approach that can identify temporal and nonlinear pathways through which social interactions may confer risk for depression. Our unique analysis of the importance of input features enabled us to interpret the association between social interactions and depressive symptoms. Collectively, we observed a return to pre-pandemic patterns a year into the pandemic, with reduced gender and age differences during the pandemic closures. This pattern suggests that the system of social influences in adolescence was affected by COVID-19, and that this effect was attenuated in more chronic stages of the pandemic.

3.
J Immunol ; 184(8): 4447-54, 2010 Apr 15.
Article in English | MEDLINE | ID: mdl-20220092

ABSTRACT

L-selectin is an adhesion molecule expressed by neutrophils that broadly directs their infiltration in to sites of inflammation. It is also present at relatively high levels in the serum of normal individuals. It is well established that L-selectin is efficiently shed from the surface of neutrophils upon their activation, a process that regulates its density and binding activity. Neutrophil programmed cell death is critical for the resolution of inflammation, and L-selectin downregulation is induced during this process as well. The mechanisms underpinning this latter process are much less understood, and were investigated in this study. Using a disintegrin and metalloprotease (ADAM)-17 radiation chimeric mice, we demonstrate for the first time that during early events of death receptor-mediated neutrophil apoptosis, L-selectin downregulation occurs primarily by ADAM17-mediated shedding. This was observed as well upon using shRNA to knock down ADAM17 expression in Jurkat cells, a well-studied cell line in terms of the molecular processes involved in the induction of apoptosis. These findings directly reveal that ADAM17 activity occurs during programmed cell death. Hence, the cleavage of particular ADAM17 substrates may be an additional component of the anti-inflammatory program initiated by apoptotic neutrophils. Of interest was that during later stages of induced leukocyte apoptosis, soluble L-selectin production occurred independent of ADAM17, as well as membrane events, such as blebbing and microparticle production. This process may provide an explanation for the lack of diminished serum L-selectin levels in ADAM17-null mice, and suggests a mechanism for the homeostatic maintenance of soluble L-selectin levels in the blood of healthy individuals.


Subject(s)
ADAM Proteins/physiology , Apoptosis/immunology , L-Selectin/biosynthesis , Neutrophils/immunology , Neutrophils/metabolism , Receptors, Death Domain/physiology , ADAM Proteins/deficiency , ADAM Proteins/genetics , ADAM17 Protein , Animals , Apoptosis/genetics , Cells, Cultured , Humans , Inflammation Mediators/blood , Inflammation Mediators/physiology , Jurkat Cells , L-Selectin/blood , L-Selectin/metabolism , Mice , Mice, Knockout , Neutrophil Activation/genetics , Neutrophil Activation/immunology , Neutrophil Infiltration/genetics , Neutrophil Infiltration/immunology , Neutrophils/cytology , Radiation Chimera/genetics , Radiation Chimera/immunology , Receptors, Death Domain/blood , Receptors, Death Domain/genetics , Solubility , Time Factors
4.
Nat Commun ; 13(1): 5055, 2022 08 27.
Article in English | MEDLINE | ID: mdl-36030289

ABSTRACT

Antiretroviral therapy (ART) is not curative due to the persistence of a reservoir of HIV-infected cells, particularly in tissues such as lymph nodes, with the potential to cause viral rebound after treatment cessation. In this study, fingolimod (FTY720), a lysophospholipid sphingosine-1-phosphate receptor modulator is administered to SIV-infected rhesus macaques at initiation of ART to block the egress from lymphoid tissues of natural killer and T-cells, thereby promoting proximity between cytolytic cells and infected CD4+ T-cells. When compared with the ART-only controls, FTY720 treatment during the initial weeks of ART induces a profound lymphopenia and increases frequencies of CD8+ T-cells expressing perforin in lymph nodes, but not their killing capacity; FTY720 also increases frequencies of cytolytic NK cells in lymph nodes. This increase of cytolytic cells, however, does not limit measures of viral persistence during ART, including intact proviral genomes. After ART interruption, a subset of animals that initially receives FTY720 displays a modest delay in viral rebound, with reduced plasma viremia and frequencies of infected T follicular helper cells. Further research is needed to optimize the potential utility of FTY720 when coupled with strategies that boost the antiviral function of T-cells in lymphoid tissues.


Subject(s)
HIV Infections , Simian Acquired Immunodeficiency Syndrome , Simian Immunodeficiency Virus , Animals , Anti-Retroviral Agents , CD4-Positive T-Lymphocytes , Fingolimod Hydrochloride , Macaca mulatta , Viral Load
5.
Dev Psychol ; 57(10): 1633-1647, 2021 Oct.
Article in English | MEDLINE | ID: mdl-34807686

ABSTRACT

Adolescence is a critical period for social development, which COVID-19 has dramatically altered. Quarantined youths had limited in-person interactions with peers. The present study used an intensive longitudinal design to investigate changes in interpersonal dynamics and mental health during COVID-19. Specifically, we investigated whether the associations between different social contexts-that is, "spillover"-changed during COVID-19 and whether changes in social interactions during COVID-19 was associated with changes in depressive symptoms. Approximately 1 year prior to the onset of COVID-19, 139 youths reported depressive symptoms and daily interactions with parents, siblings, and friends, every day for 21 days via online questionnaires. Shortly after schools closed due to COVID-19, 115 of these youths completed a similar 28-day diary. Analyses included 112 youths (62 girls; 73% Caucasian; Mage = 11.77, range = 8 to 15 in Wave 1) who completed at least 13 diary days in each data wave. Our results show that younger adolescents experienced significant decreases in negative and positive interactions with friends, whereas older adolescents showed significant decreases in negative interactions with friends and significant increases in positive interactions with siblings. As predicted, within-day spillover of positive interactions and person-level association of negative interactions increased within the family during COVID-19, whereas within-day spillover of positive interactions between family and friends decreased. We also found a dramatic increase in depressive symptoms. More negative interactions and fewer positive interactions with family members were associated with changes in depressive symptoms. Our study sheds light on how youths' social development may be impacted by COVID-19. (PsycInfo Database Record (c) 2021 APA, all rights reserved).


Subject(s)
COVID-19 , Mental Health , Adolescent , Female , Friends , Humans , Parents , SARS-CoV-2
6.
Cells ; 10(6)2021 05 23.
Article in English | MEDLINE | ID: mdl-34071075

ABSTRACT

Chronic hepatitis B virus (HBV) infection is the major etiology of hepatocellular carcinoma (HCC), frequently with HBV integrating into the host genome. HBV integration, found in 85% of HBV-associated HCC (HBV-HCC) tissue samples, has been suggested to be oncogenic. Here, we investigated the potential of HBV-HCC driver identification via the characterization of recurrently targeted genes (RTGs). A total of 18,596 HBV integration sites from our in-house study and others were analyzed. RTGs were identified by applying three criteria: at least two HCC subjects, reported by at least two studies, and the number of reporting studies. A total of 396 RTGs were identified. Among the 28 most frequent RTGs, defined as affected in at least 10 HCC patients, 23 (82%) were associated with carcinogenesis and 5 (18%) had no known function. Available breakpoint positions from the three most frequent RTGs, TERT, MLL4/KMT2B, and PLEKHG4B, were analyzed. Mutual exclusivity of TERT promoter mutation and HBV integration into TERT was observed. We present an RTG consensus through comprehensive analysis to enable the potential identification and discovery of HCC drivers for drug development and disease management.


Subject(s)
Carcinoma, Hepatocellular/drug therapy , Carcinoma, Hepatocellular/etiology , Hepatitis B virus/drug effects , Hepatitis B, Chronic/drug therapy , Liver Neoplasms/drug therapy , Aged , Carcinogenesis/drug effects , Carcinogenesis/genetics , Carcinoma, Hepatocellular/genetics , Disease Management , Female , Humans , Liver Neoplasms/etiology , Liver Neoplasms/metabolism , Male , Middle Aged , Oncogenes/drug effects , Oncogenes/physiology
SELECTION OF CITATIONS
SEARCH DETAIL